- Conditions
- Maxillary Sinusitis
- Interventions
- azithromycin SR (Zithromax; compound: CP-62,993), placebo, levofloxacin
- Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 541 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 59
- States / cities
- Alabaster, Alabama • Birmingham, Alabama • Hueytown, Alabama + 37 more
Source: ClinicalTrials.gov public record
Updated May 10, 2011 · Synced May 21, 2026, 9:05 PM EDT